# PREVDUO

NDC: 42023-269
Generic name: neostigmine methylsulfate and glycopyrrolate
Labeler / Manufacturer: Endo USA
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20230515

FDA application: NDA216903

## Active ingredients

- GLYCOPYRROLATE: .2 mg/mL
- NEOSTIGMINE METHYLSULFATE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42023-269"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42023-269
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd8ad38f-247b-4948-a13c-8f3a4921b4f1